Sunmax Biotechnology Co

Sunmax Biotechnology Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunmax Biotechnology Co (4728.TWO) as of Oct 17, 2026 is 998.31 M TWD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 926.96 M TWD — a change of 7.70% (higher).

EBITDA

998.31 MTWD

YoY

7.70%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunmax Biotechnology Co is 2025 998.31 M TWD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunmax Biotechnology Co was 2024 926.96 M TWD. It decreases by 7.70% higher compared to the previous year.

The Sunmax Biotechnology Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
63.93 M TWD
Jan 1, 2019
177.52 M TWD
Jan 1, 2020
346.45 M TWD
Jan 1, 2021
362.63 M TWD
Jan 1, 2022
777.68 M TWD
Jan 1, 2023
912.47 M TWD
Jan 1, 2024
926.96 M TWD
Jan 1, 2025
998.31 M TWD
The Sunmax Biotechnology Co EBITDA history
YEAREBITDAYoY
998.31 MTWD+7.70%
926.96 MTWD+1.59%
912.47 MTWD+17.33%
777.68 MTWD+114.45%
362.63 MTWD+4.67%
346.45 MTWD+95.16%
177.52 MTWD+177.69%
63.93 MTWD+381.67%
13.27 MTWD+328.54%
3.10 MTWD-106.46%
-47.96 MTWD-465.13%
13.14 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Sunmax Biotechnology Co Stock analysis

What does Sunmax Biotechnology Co do? Sunmax Biotechnology Co Ltd is a company based in Tainan, Taiwan, operating within the Health Care sector, specifically in the Biotechnology industry. Founded through an IPO on January 25, 2010, the company employs 37 people. It develops, manufactures, and commercializes medical devices, biomedical materials, and bio-surgical products. The company's product range includes collagen, collagen implants, microfiber collagen hemostat, collagen absorbable hemostat pads, healthcare products, and medical collagen application equipment. These products are utilized in both medical and beauty care industries. Sunmax Biotechnology distributes its products primarily within Taiwan, Mainland China, and other regions. The company maintains a website at https://www.sunmaxbiotech.com/ for further information. Its headquarters are located in Tainan, Taiwan, and it is listed on the Taiwan Stock Exchange under the ticker 4728.TWO with ISIN TW0004728001. The company's activities focus on the development and application of collagen-based technologies for medical and cosmetic purposes. Sunmax Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunmax Biotechnology Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunmax Biotechnology Co is 998.31 M TWD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Sunmax Biotechnology Co changed from 926.96 M TWD to 998.31 M TWD, representing a 7.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Sunmax Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Sunmax Biotechnology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Sunmax Biotechnology Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Sunmax Biotechnology Co